TY - JOUR
T1 - Extracellular vesicles as a drug delivery system
T2 - A systematic review of preclinical studies
AU - Escudé Martinez de Castilla, Pol
AU - Tong, Lingjun
AU - Huang, Chenyuan
AU - Sofias, Alexandros Marios
AU - Pastorin, Giorgia
AU - Chen, Xiaoyuan
AU - Storm, Gert
AU - Schiffelers, Raymond M
AU - Wang, Jiong-Wei
N1 - Copyright © 2021 Elsevier B.V. All rights reserved.
PY - 2021/8
Y1 - 2021/8
N2 - During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug delivery system. Here, we assess their pre-clinical applications, in the form of a systematic review. For each study published in the past decade, disease models, animal species, EV donor cell types, active pharmaceutical ingredients (APIs), EV surface modifications, API loading methods, EV size and charge, estimation of EV purity, presence of biodistribution studies and administration routes were quantitatively analyzed in a defined and reproducible way. We have interpreted the trends we observe over the past decade, to define the niches where to apply EVs for drug delivery in the future and to provide a basis for regulatory guidelines.
AB - During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug delivery system. Here, we assess their pre-clinical applications, in the form of a systematic review. For each study published in the past decade, disease models, animal species, EV donor cell types, active pharmaceutical ingredients (APIs), EV surface modifications, API loading methods, EV size and charge, estimation of EV purity, presence of biodistribution studies and administration routes were quantitatively analyzed in a defined and reproducible way. We have interpreted the trends we observe over the past decade, to define the niches where to apply EVs for drug delivery in the future and to provide a basis for regulatory guidelines.
KW - Liposomes
KW - Systematic review
KW - Drug Delivery
KW - Extracellular Vesicles
KW - Preclinical animal models
KW - Clinical trial
U2 - 10.1016/j.addr.2021.05.011
DO - 10.1016/j.addr.2021.05.011
M3 - Article
C2 - 34015418
SN - 0169-409X
VL - 175
SP - 1
EP - 39
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
M1 - 113801
ER -